-
Timing Matters: Missed Opportunity to Prevent RSV Cases in Older Adults in Germany: A Markov Model Analysis
Sep 9, 2025, 16:22 PM -
What Tips the Scale Toward Reimbursement? A Dutch-led Comparison of Pharmacoeconomic Evaluations Across the Netherlands, Sweden, and the United Kingdom
Sep 9, 2025, 16:22 PM -
Predicting Self-Efficacy in Managing Type 2 Diabetes: Results From a Low-Income, Less Educated Community of Quetta City, Pakistan
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis of Add-On Vericiguat to Standard Treatment in Thai Patients With Heart Failure and Reduced Ejection Fraction
Sep 9, 2025, 16:22 PM -
When Trials Don’t Meet: A Retrospective Statistical Analysis Using Matching-Adjusted Indirect Comparison (MAIC) and Individual Patient Data (IPD) to Compare Catiolanze® With Other Preservative-Free (PF) Latanoprost in Open-Angle Glaucoma (OAG)
Sep 9, 2025, 16:22 PM -
Early Access Programs and Pricing and Reimbursement Agreements in Portugal for Orphan Medicines Centrally Approved in the European Union
Sep 9, 2025, 16:22 PM -
Maximizing Acceptance of Patient-Reported Outcome Data in German HTA Decision Making: Results From a Horizon Scan
Sep 9, 2025, 16:22 PM -
How Do Neurologists Perceive the Organization and Functioning of Care in Their Multiple Sclerosis Units?
Sep 9, 2025, 16:22 PM -
Budget Impact of an Ambulatory Minimally Invasive Surgical Treatment in an Italian Public Hospital
Sep 9, 2025, 16:22 PM -
Collateral Impact of Government-Intervened Health Insurers on the Colombian Health System: A Causal Analysis of Financial, Health, and Perception Outcomes (2023-2025)
Sep 9, 2025, 16:22 PM -
Unraveling the Challenges of Multiplex Cell Culture Technology Using the HTA Core Model
Sep 9, 2025, 16:22 PM -
Colorectal Cancer Mortality Overview in Mexico 1998-2023
Sep 9, 2025, 16:22 PM -
Comparing Health-Related Quality of Life in Obese Patients With and Without Bariatric Surgery: A Cross-Sectional Study in a Multi-Ethnic Asian Population in Singapore
Sep 9, 2025, 16:22 PM -
Value-Based Pricing and Budget Impact Analysis for Multi-Indication Drugs: A Case Study of Oncology Medications
Sep 9, 2025, 16:22 PM -
Caregiver Quality of Life in Orphan Drug Health Technology Assessment Submissions in Europe: A Comparative Analysis
Sep 9, 2025, 16:22 PM -
Large Language Model (LLM) as Catalyst for Rapid and Efficient Critical Appraisal of Epidemiological Research
Sep 9, 2025, 16:22 PM -
From Efficiency to Equity: Considerations in NICE Technology Appraisals
Sep 9, 2025, 16:22 PM -
A Generalizable Discrete Event Simulation Framework to Assess Clinical and Economic Impact of Prescription Protocol Revisions
Sep 9, 2025, 16:22 PM -
A Retrospective Analysis of Reimbursement Timelines in Ireland: What Does a 10-Year Analysis Show?
Sep 9, 2025, 16:22 PM -
Microsimulation Model to Estimate the Clinical and Cost Burden of Adverse Events Related to Long-Term Oral Corticosteroid Usage in Autoimmune Diseases in the United States
Sep 9, 2025, 16:22 PM